AIM ImmunoTech (AIM) Earnings Date, Estimates & Call Transcripts $3.01 +0.18 (+6.36%) Closing price 04:00 PM EasternExtended Trading$2.96 -0.05 (-1.66%) As of 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AIM ImmunoTech Earnings Summary AIM ImmunoTech announced Q2 2024 earnings on August 14, 2024, reporting an EPS of -$3.00. Quarterly revenue was reported to be $0.05 million. With a trailing EPS of -$24.00, AIM ImmunoTech's earnings are expected to decrease next year, from ($0.30) to ($0.35) per share. Q2 2024 Earnings ResourcesQ2 2024 Earnings ReportLatest Q2 2024 Earnings DateAug. 14EstimatedActual Revenue (Aug. 14) $0.05M Get AIM ImmunoTech Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AIM ImmunoTech and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataAIM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.AIM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. AIM ImmunoTech Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($0.30) EPSNext Year EPS Consensus Estimate ($0.35) EPS AIM ImmunoTech Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/14/2024Q2 2024--$3.00--$0.03-$0.05M5/16/2024Q1 2024--$12.00--$0.12-$0.04M3/29/2024Q4 2023--$26.00--$0.26-$0.07M11/15/2023Q3 2023-$11.00-$16.00 -$5.00-$0.16-$0.05M8/15/2023Q2 2023--$10.00--$0.10-$0.04M AIM ImmunoTech Earnings - Frequently Asked Questions When did AIM ImmunoTech announce their last quarterly earnings? AIM ImmunoTech (NYSE:AIM) last announced its quarterly earning data on Wednesday, August 14, 2024. Learn more on AIM's earnings history. How much revenue does AIM ImmunoTech generate each year? AIM ImmunoTech (NYSE:AIM) has a recorded annual revenue of $146,000.00. How much profit does AIM ImmunoTech generate each year? AIM ImmunoTech (NYSE:AIM) has a recorded net income of -$28.96 million. AIM has generated -$24.00 earnings per share over the last four quarters. What is AIM ImmunoTech's EPS forecast for next year? AIM ImmunoTech's earnings are expected to decrease from ($0.30) per share to ($0.35) per share in the next year. More Earnings Resources from MarketBeat Related Companies SNPX Earnings Results RNAZ Earnings Results CLRB Earnings Results TRAW Earnings Results BMRA Earnings Results SNSE Earnings Results BTAI Earnings Results ADXN Earnings Results TLPH Earnings Results CHRO Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Why Robinhood Just Added Upside Potential After a Q2 Earnings DipMicrosoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead? This page (NYSE:AIM) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AIM ImmunoTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AIM ImmunoTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
